NCT03175432 2026-04-15
Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
M.D. Anderson Cancer Center
The Methodist Hospital Research Institute
ImmunityBio, Inc.
Dana-Farber Cancer Institute
Fondazione Melanoma Onlus